Cargando…

Dosimetric justification for the use of volumetric modulated arc therapy in head and neck cancer—A systematic review of the literature

INTRODUCTION: Radiotherapy for head and neck cancer (HNC) has evolved rapidly in the past decades from conformal three‐dimensional technique (3D‐CRT) to intensity‐modulated radiotherapy (IMRT) and volumetric‐modulated arc therapy (VMAT). This paper presents a dosimetric comparative study between VMA...

Descripción completa

Detalles Bibliográficos
Autores principales: Buciuman, Nikolett, Marcu, Loredana G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513433/
https://www.ncbi.nlm.nih.gov/pubmed/34667842
http://dx.doi.org/10.1002/lio2.642
_version_ 1784583211559419904
author Buciuman, Nikolett
Marcu, Loredana G.
author_facet Buciuman, Nikolett
Marcu, Loredana G.
author_sort Buciuman, Nikolett
collection PubMed
description INTRODUCTION: Radiotherapy for head and neck cancer (HNC) has evolved rapidly in the past decades from conformal three‐dimensional technique (3D‐CRT) to intensity‐modulated radiotherapy (IMRT) and volumetric‐modulated arc therapy (VMAT). This paper presents a dosimetric comparative study between VMAT and IMRT delivery based on current literature, while also presenting the potential challenges encountered with volumetric arc therapy. METHODS: A systematic search of the scientific literature was conducted within Medline/Pubmed databases. A number of 13 papers fulfilled the search criteria which was based on the main objective to evaluate dosimetric characteristics of comparative treatment delivery with VMAT vs IMRT in HNC. RESULTS: Overall, from a dosimetric perspective, dose delivery via VMAT and IMRT present comparable results. Beside the delivery technique, target volume coverage also depends on the planner's expertise as well as the employed planning algorithm. At times, the superiority of VMAT emerges from the improved sparing of normal tissue, reduction of monitor units (MU) and of treatment delivery time. Similar to IMRT, one of the most important challenges of VMAT is the risk of developing secondary cancer due to the higher number of MUs compared to 3D‐CRT. CONCLUSIONS: Based on the comparative results with the more established IMRT, VMAT in HNC can be safely delivered either as a single treatment or combined with other techniques.
format Online
Article
Text
id pubmed-8513433
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-85134332021-10-18 Dosimetric justification for the use of volumetric modulated arc therapy in head and neck cancer—A systematic review of the literature Buciuman, Nikolett Marcu, Loredana G. Laryngoscope Investig Otolaryngol Head and Neck, and Tumor Biology INTRODUCTION: Radiotherapy for head and neck cancer (HNC) has evolved rapidly in the past decades from conformal three‐dimensional technique (3D‐CRT) to intensity‐modulated radiotherapy (IMRT) and volumetric‐modulated arc therapy (VMAT). This paper presents a dosimetric comparative study between VMAT and IMRT delivery based on current literature, while also presenting the potential challenges encountered with volumetric arc therapy. METHODS: A systematic search of the scientific literature was conducted within Medline/Pubmed databases. A number of 13 papers fulfilled the search criteria which was based on the main objective to evaluate dosimetric characteristics of comparative treatment delivery with VMAT vs IMRT in HNC. RESULTS: Overall, from a dosimetric perspective, dose delivery via VMAT and IMRT present comparable results. Beside the delivery technique, target volume coverage also depends on the planner's expertise as well as the employed planning algorithm. At times, the superiority of VMAT emerges from the improved sparing of normal tissue, reduction of monitor units (MU) and of treatment delivery time. Similar to IMRT, one of the most important challenges of VMAT is the risk of developing secondary cancer due to the higher number of MUs compared to 3D‐CRT. CONCLUSIONS: Based on the comparative results with the more established IMRT, VMAT in HNC can be safely delivered either as a single treatment or combined with other techniques. John Wiley & Sons, Inc. 2021-08-16 /pmc/articles/PMC8513433/ /pubmed/34667842 http://dx.doi.org/10.1002/lio2.642 Text en © 2021 The Authors. Laryngoscope Investigative Otolaryngology published by Wiley Periodicals LLC on behalf of The Triological Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Head and Neck, and Tumor Biology
Buciuman, Nikolett
Marcu, Loredana G.
Dosimetric justification for the use of volumetric modulated arc therapy in head and neck cancer—A systematic review of the literature
title Dosimetric justification for the use of volumetric modulated arc therapy in head and neck cancer—A systematic review of the literature
title_full Dosimetric justification for the use of volumetric modulated arc therapy in head and neck cancer—A systematic review of the literature
title_fullStr Dosimetric justification for the use of volumetric modulated arc therapy in head and neck cancer—A systematic review of the literature
title_full_unstemmed Dosimetric justification for the use of volumetric modulated arc therapy in head and neck cancer—A systematic review of the literature
title_short Dosimetric justification for the use of volumetric modulated arc therapy in head and neck cancer—A systematic review of the literature
title_sort dosimetric justification for the use of volumetric modulated arc therapy in head and neck cancer—a systematic review of the literature
topic Head and Neck, and Tumor Biology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513433/
https://www.ncbi.nlm.nih.gov/pubmed/34667842
http://dx.doi.org/10.1002/lio2.642
work_keys_str_mv AT buciumannikolett dosimetricjustificationfortheuseofvolumetricmodulatedarctherapyinheadandneckcancerasystematicreviewoftheliterature
AT marculoredanag dosimetricjustificationfortheuseofvolumetricmodulatedarctherapyinheadandneckcancerasystematicreviewoftheliterature